AR009407A1 - Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares - Google Patents
Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovascularesInfo
- Publication number
- AR009407A1 AR009407A1 ARP970105144A ARP970105144A AR009407A1 AR 009407 A1 AR009407 A1 AR 009407A1 AR P970105144 A ARP970105144 A AR P970105144A AR P970105144 A ARP970105144 A AR P970105144A AR 009407 A1 AR009407 A1 AR 009407A1
- Authority
- AR
- Argentina
- Prior art keywords
- progesterone
- prepare
- pharmaceutical composition
- composition useful
- incidence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de progesterona para preparar una composicion farmacéutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares que comprende una cantidad eficaz deprogesteron a y un vehículo farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/743,153 US5985861A (en) | 1996-11-04 | 1996-11-04 | Progesterone for treating or reducing ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
AR009407A1 true AR009407A1 (es) | 2000-04-12 |
Family
ID=24987712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970105144A AR009407A1 (es) | 1996-11-04 | 1997-11-04 | Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares |
Country Status (27)
Country | Link |
---|---|
US (2) | US5985861A (es) |
EP (1) | EP0956023B1 (es) |
KR (1) | KR100434623B1 (es) |
CN (1) | CN100341512C (es) |
AR (1) | AR009407A1 (es) |
AT (1) | ATE321558T1 (es) |
AU (1) | AU715740C (es) |
BR (1) | BR9710918A (es) |
CA (1) | CA2270565C (es) |
DE (1) | DE69735598T2 (es) |
DK (1) | DK0956023T3 (es) |
ES (1) | ES2262196T3 (es) |
GE (1) | GEP20022630B (es) |
HK (1) | HK1020534A1 (es) |
HU (1) | HUP9904045A3 (es) |
IL (1) | IL127455A (es) |
LV (1) | LV12342B (es) |
MA (1) | MA24391A1 (es) |
MY (1) | MY121627A (es) |
NO (1) | NO324278B1 (es) |
NZ (1) | NZ335306A (es) |
PE (1) | PE9899A1 (es) |
PT (1) | PT956023E (es) |
RO (1) | RO120607B1 (es) |
UA (1) | UA66772C2 (es) |
WO (1) | WO1998019681A1 (es) |
ZA (1) | ZA979862B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6056972A (en) * | 1997-02-26 | 2000-05-02 | Dimera, Llc | Method for reducing coronary artery reactivity |
US6602487B1 (en) | 1997-02-26 | 2003-08-05 | Dimera Incorporated | Methods and tests for producing and for inhibiting coronary artery vasospasms |
US20040234606A1 (en) * | 1997-09-12 | 2004-11-25 | Levine Howard L. | Localized vaginal delivery without detrimental blood levels |
DE69819748T2 (de) | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
GB0107383D0 (en) * | 2001-03-23 | 2001-05-16 | Univ Edinburgh | Lipid profile modulation |
US8425892B2 (en) | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US20030114394A1 (en) * | 2001-10-29 | 2003-06-19 | Levine Howard L. | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
ATE461681T1 (de) * | 2003-04-29 | 2010-04-15 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
DE102005027004B4 (de) * | 2005-06-10 | 2020-03-19 | Continental Automotive Gmbh | Scheibenwaschvorrichtung |
US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
ES2645630T3 (es) | 2008-02-04 | 2017-12-07 | Ferring B.V. | Anillos intravaginales monolíticos que comprenden progesterona y métodos de fabricación y usos de los mismos |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
US10098894B2 (en) | 2014-07-29 | 2018-10-16 | Therapeuticsmd, Inc. | Transdermal cream |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2020051329A1 (en) * | 2018-09-07 | 2020-03-12 | Trustees Of Dartmouth College | C19 scaffolds and steroids and methods of use and manufacture thereof |
US11512107B2 (en) | 2018-09-07 | 2022-11-29 | Trustees Of Dartmouth College | Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1124906A1 (ru) * | 1982-05-25 | 1984-11-23 | Ивановский государственный медицинский институт им.А.С.Бубнова | Способ коррекции ишемических повреждений консервированной донорской почки |
EP0501523B1 (en) * | 1983-11-14 | 1997-04-09 | Columbia Laboratories, Inc. | Bioadhesive compositions |
US5543150A (en) * | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
-
1996
- 1996-11-04 US US08/743,153 patent/US5985861A/en not_active Expired - Lifetime
-
1997
- 1997-11-03 MA MA24853A patent/MA24391A1/fr unknown
- 1997-11-03 ZA ZA9709862A patent/ZA979862B/xx unknown
- 1997-11-04 UA UA99052985A patent/UA66772C2/uk unknown
- 1997-11-04 AR ARP970105144A patent/AR009407A1/es unknown
- 1997-11-04 RO RO99-00508A patent/RO120607B1/ro unknown
- 1997-11-04 KR KR10-1999-7003965A patent/KR100434623B1/ko not_active IP Right Cessation
- 1997-11-04 PE PE1997000985A patent/PE9899A1/es not_active Application Discontinuation
- 1997-11-04 CN CNB971994145A patent/CN100341512C/zh not_active Expired - Fee Related
- 1997-11-04 PT PT97946681T patent/PT956023E/pt unknown
- 1997-11-04 NZ NZ335306A patent/NZ335306A/xx not_active IP Right Cessation
- 1997-11-04 HU HU9904045A patent/HUP9904045A3/hu unknown
- 1997-11-04 GE GEAP19974830A patent/GEP20022630B/en unknown
- 1997-11-04 ES ES97946681T patent/ES2262196T3/es not_active Expired - Lifetime
- 1997-11-04 WO PCT/US1997/020923 patent/WO1998019681A1/en active IP Right Grant
- 1997-11-04 AU AU51801/98A patent/AU715740C/en not_active Ceased
- 1997-11-04 BR BR9710918-5A patent/BR9710918A/pt not_active Application Discontinuation
- 1997-11-04 DE DE69735598T patent/DE69735598T2/de not_active Expired - Fee Related
- 1997-11-04 CA CA002270565A patent/CA2270565C/en not_active Expired - Fee Related
- 1997-11-04 DK DK97946681T patent/DK0956023T3/da active
- 1997-11-04 MY MYPI97005220A patent/MY121627A/en unknown
- 1997-11-04 EP EP97946681A patent/EP0956023B1/en not_active Expired - Lifetime
- 1997-11-04 AT AT97946681T patent/ATE321558T1/de not_active IP Right Cessation
-
1998
- 1998-12-09 IL IL12745598A patent/IL127455A/xx not_active IP Right Cessation
-
1999
- 1999-02-01 US US09/240,610 patent/US6054447A/en not_active Expired - Lifetime
- 1999-05-03 NO NO19992140A patent/NO324278B1/no unknown
- 1999-05-28 LV LVP-99-88A patent/LV12342B/en unknown
- 1999-11-30 HK HK99105558A patent/HK1020534A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR009407A1 (es) | Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares | |
PT1011682E (pt) | Contraceptivo hormonal | |
DE69512374D1 (de) | Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz | |
ES2174953T3 (es) | Composiciones dermatologicas que contienen peroxido de benzoilo y un compuesto que reduce la irritacion de la piel. | |
WO2001080713A3 (en) | Methods for non-permanent occlusion of a uterine artery | |
CA2289717A1 (en) | Novel therapy for constipation | |
KR970704429A (ko) | 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases) | |
WO2000027424B1 (en) | Upregulation of endogenous prostaglandins to lower intraocular pressure | |
AR009356A1 (es) | Compuesto de 1-4 heterociclico, inhibidor de la metaloproteasa y su uso para preparar una composicion farmaceutica y para prevenir o tratar una enfermedad asociada con la actividad de la metalo proteasa y la caquexia | |
DK0880350T3 (da) | Behandling af dissemineret sklerose | |
CL2011000017A1 (es) | Uso de una composicion farmaceutica que comprende i) 0,5 a 3 mg de un estrogeno seleccionado de estradiol libre, estradiol esterificado y estrogenos conjugados de equinos, ii) 1,5 a 3,75 de acetato de nomegestrol, y iii) excipientes farmaceuticos adecuados, para tratar deficiencias estrogenicas en mujeres postmenopausicas (divisional de solicitud 1997-02114). | |
CO4900022A1 (es) | Composicion topica y metodo para incrementar la sintesis de la barrera del lipido la barrera de lipido utilizando dicha composicion | |
BR9509006A (pt) | Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele | |
MX9603596A (es) | Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas. | |
ES2180690T3 (es) | Preparacion de composiciones que comprenden st1435 para aplicacion topica. | |
ES2183220T3 (es) | Curacion de heridas y tratamientos de la fibrosis. | |
CA2193363A1 (en) | Therapeutic agent for liver regeneration | |
DE69710333D1 (de) | Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie | |
ES2175437T3 (es) | Composicion de enalapril y losartan. | |
CO4930269A1 (es) | Composiciones farmaceuticas | |
ES2189886T3 (es) | Composicion farmaceutica para aplicacion topica. | |
BR0013272A (pt) | Uso de uma substância que inibe a produção de e/ou o efeito dos estrogênios, ou de uma composição contendo a citada substância, e, composição cosmética para aplicação tópica | |
AR008155A1 (es) | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. | |
FR2760363B1 (fr) | Composition pour le traitement topique des affections de la peau et des phaneres | |
MD742B1 (en) | Regenerative remedy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |